Literature DB >> 23125329

Detecting and managing hereditary colorectal cancer syndromes in your practice.

Brandie Heald1, James Church, Thomas Plesec, Carol A Burke.   

Abstract

Hereditary syndromes account for 5% to 10% of cases of colorectal cancer. In clinical practice, patients with these syndromes need to be identified to ensure that they and their families receive genetic counseling and testing and appropriate risk-reducing treatment. Genetic testing can offer a precise diagnosis. It allows for risk stratification and focused management and surveillance.

Entities:  

Mesh:

Year:  2012        PMID: 23125329     DOI: 10.3949/ccjm.79a.11165

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  2 in total

1.  Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial.

Authors:  Anita Y Kinney; Watcharaporn Boonyasiriwat; Scott T Walters; Lisa M Pappas; Antoinette M Stroup; Marc D Schwartz; Sandra L Edwards; Amy Rogers; Wendy K Kohlmann; Kenneth M Boucher; Sally W Vernon; Rebecca G Simmons; Jan T Lowery; Kristina Flores; Charles L Wiggins; Deirdre A Hill; Randall W Burt; Marc S Williams; John C Higginbotham
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

2.  Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study.

Authors:  Nour El Hoda S Ismael; Samar A El Sheikh; Suzan M Talaat; Eman M Salem
Journal:  Open Access Maced J Med Sci       Date:  2017-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.